ZAMAGNI, CLAUDIO
ZAMAGNI, CLAUDIO
Characterization of BRCA Deficiency in Ovarian Cancer
2023 Barbero, Giovanna; Zuntini, Roberta; Magini, Pamela; Desiderio, Laura; Bonaguro, Michela; Perrone, Anna Myriam; Rubino, Daniela; Grippa, Mina; De Leo, Antonio; Ceccarelli, Claudio; Godino, Lea; Miccoli, Sara; Ferrari, Simona; Santini, Donatella; De Iaco, Pierandrea; Zamagni, Claudio; Innella, Giovanni; Turchetti, Daniela
Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study)
2023 Ferioli, Martina; Benini, Anna; Malizia, Claudio; Forlani, Ludovica; Medici, Federica; Laghi, Viola; Ma, Johnny; Galuppi, Andrea; Cilla, Savino; Buwenge, Milly; Macchia, Gabriella; Zamagni, Claudio; Tagliaferri, Luca; Perrone, Anna Myriam; De Iaco, Pierandrea; Strigari, Lidia; Morganti, Alessio Giuseppe; Arcelli, Alessandra
Combination of Electrochemotherapy with Radiotherapy: A Comprehensive, Systematic, PRISMA-Compliant Review of Efficacy and Potential Radiosensitizing Effects in Tumor Control
2023 Ferioli, Martina; Perrone, Anna M; Buwenge, Milly; Arcelli, Alessandra; Vadala', Maria; Fionda, Bruno; Malato, Maria C; De Iaco, Pierandrea; Zamagni, Claudio; Cammelli, Silvia; Tagliaferri, Luca; Morganti, Alessio G
Factors predicting BRCA1/2 pathogenic variants in patients with ovarian cancer: a systematic review with meta-analysis
2023 Innella, Giovanni; Godino, Lea; Erini, Giulia; De Leo, Antonio; Santini, Donatella; Perrone, Anna Myriam; De Iaco, Pierandrea; Zamagni, Claudio; Turchetti, Daniela
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice
2023 de Biase, Dario; Maloberti, Thais; Corradini, Angelo Gianluca; Rosini, Francesca; Grillini, Marco; Ruscelli, Martina; Coluccelli, Sara; Altimari, Annalisa; Gruppioni, Elisa; Sanza, Viviana; Turchetti, Daniela; Galuppi, Andrea; Ferioli, Martina; Giunchi, Susanna; Dondi, Giulia; Tesei, Marco; Ravegnini, Gloria; Abbati, Francesca; Rubino, Daniela; Zamagni, Claudio; De Iaco, Pierandrea; Santini, Donatella; Ceccarelli, Claudio; Perrone, Anna Myriam; Tallini, Giovanni; De Leo, Antonio
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going
2023 Mazzitelli C.; Santini D.; Corradini A.G.; Zamagni C.; Trere' D.; Montanaro L.; Taffurelli M.
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival
2023 Coada, Camelia Alexandra; Dondi, Giulia; Ravegnini, Gloria; Di Costanzo, Stella; Tesei, Marco; Fiuzzi, Enrico; Di Stanislao, Marco; Giunchi, Susanna; Zamagni, Claudio; Bovicelli, Alessandro; Hrelia, Patrizia; Angelini, Sabrina; De Iaco, Pierandrea; Perrone, Anna Myriam
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma
2023 Perrone, Anna Myriam; Coada, Camelia Alexandra; Ravegnini, Gloria; De Leo, Antonio; Damiano, Giuseppe; De Crescenzo, Eugenia; Tesei, Marco; Di Costanzo, Stella; Genovesi, Lucia; Rubino, Daniela; Zamagni, Claudio; De Iaco, Pierandrea
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma
2023 Ruscelli, Martina; Maloberti, Thais; Corradini, Angelo Gianluca; Rosini, Francesca; Querzoli, Giulia; Grillini, Marco; Altimari, Annalisa; Gruppioni, Elisa; Sanza, Viviana; Costantino, Alessia; Ciudino, Riccardo; Errani, Matteo; Papapietro, Alessia; Coluccelli, Sara; Turchetti, Daniela; Ferioli, Martina; Giunchi, Susanna; Dondi, Giulia; Tesei, Marco; Ravegnini, Gloria; Abbati, Francesca; Rubino, Daniela; Zamagni, Claudio; D'Angelo, Emanuela; De Iaco, Pierandrea; Santini, Donatella; Ceccarelli, Claudio; Perrone, Anna Myriam; Tallini, Giovanni; de Biase, Dario; De Leo, Antonio
Management of malignant cutaneous wounds in oncologic patients
2022 Starace M, Carpanese MA, Pampaloni F, Dika E, Pileri A, Rubino D, Alessandrini A, Zamagni C, Baraldi C, Misciali C, Patrizi A, Bianchi T, Apalla Z, Piraccini BM
Relevance of ARID1A Mutations in Endometrial Carcinomas
2022 De Leo A.; Ravegnini G.; Musiani F.; Maloberti T.; Visani M.; Sanza V.; Angelini S.; Perrone A.M.; De Iaco P.; Corradini A.G.; Rosini F.; Grillini M.; Santini D.; Ceccarelli C.; Zamagni C.; Tallini G.; de Biase D.
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification
2021 De Leo A.; de Biase D.; Lenzi J.; Barbero G.; Turchetti D.; Grillini M.; Ravegnini G.; Angelini S.; Zamagni C.; Coluccelli S.; Dondi G.; De Iaco P.; Perrone A.M.; Tallini G.; Santini D.; Ceccarelli C.
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak
2021 Perrone A.M.; Dondi G.; Giunchi S.; De Crescenzo E.; Boussedra S.; Tesei M.; D'Andrea R.; De Leo A.; Zamagni C.; Morganti A.G.; De Palma A.; De Iaco P.
Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma
2021 Giacomo Santandrea, Claudio Ceccarelli, Donatella Santini, Daniela Turchetti, Claudio Zamagni, Anna Myriam Perrone, Pierandrea De Iaco, Antonio De Leo
Radiotherapy in uterine sarcoma: a narrative review of international guidelines
2021 Ferioli, Martina; Galuppi, Andrea; Perrone, Anna Myriam; De Iaco, Pierandrea; Zamagni, Claudio; Buwenge, Milly; Morganti, Alessio Giuseppe; Cammelli, Silvia
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results
2020 Cortesi, Laura; Baldassarri, Bruna; Ferretti, Stefano; Razzaboni, Elisabetta; Bella, Mariangela; Bucchi, Lauro; Canuti, Debora; De Iaco, Pierandrea; De Santis, Giorgio; Falcini, Fabio; Galli, Vania; Godino, Lea; Leoni, Maurizio; Perrone, Anna Myriam; Pignatti, Marco; Saguatti, Gianni; Santini, Donatella; Sassoli de'Bianchi, Priscilla; Sebastiani, Federica; Taffurelli, Mario; Tazzioli, Giovanni; Turchetti, Daniela; Zamagni, Claudio; Naldoni, Carlo
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer
2020 Wurfel F.M.; Wirtz R.M.; Winterhalter C.; Taffurelli M.; Santini D.; Mandrioli A.; Veltrup E.; Rubner M.; Fasching P.A.; Wurfel W.; Zamagni C.
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed
2019 Ceccarelli C.; De Leo A.; Chieco P.; Zamagni C.; Zamagni A.; Rubino D.; Taffurelli M.; Santini D.
High-grade serous carcinoma: a comprehensive genetic and clinico-pathologic study of a heterogeneous neoplasm.
2019 G. Santandrea, A. De Leo, C. Ceccarelli, G. Barbero, S. Ferrari, D. Turchetti, D. Rubino, C. Zamagni, G. Dondi, A.M. Perrone, P. De Iaco, D. Santini.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial
2019 Dieci M.V.; Bisagni G.; Brandes A.A.; Frassoldati A.; Cavanna L.; Giotta F.; Aieta M.; Gebbia V.; Musolino A.; Garrone O.; Donadio M.; Rimanti A.; Beano A.; Zamagni C.; Soto Parra H.; Piacentini F.; Danese S.; Ferro A.; Cagossi K.; Sarti S.; Gambaro A.R.; Romito S.; Bazan V.; Amaducci L.; Moretti G.; Foschini M.P.; Balduzzi S.; Vicini R.; D'Amico R.; Griguolo G.; Guarneri V.; Conte P.F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Characterization of BRCA Deficiency in Ovarian Cancer | Barbero, Giovanna; Zuntini, Roberta; Magini, Pamela; Desiderio, Laura; Bonaguro, Michela; Perrone..., Anna Myriam; Rubino, Daniela; Grippa, Mina; De Leo, Antonio; Ceccarelli, Claudio; Godino, Lea; Miccoli, Sara; Ferrari, Simona; Santini, Donatella; De Iaco, Pierandrea; Zamagni, Claudio; Innella, Giovanni; Turchetti, Daniela | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-15-01530-v2.pdf; cancers-15-01530-s001 (1).zip |
| Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study) | Ferioli, Martina; Benini, Anna; Malizia, Claudio; Forlani, Ludovica; Medici, Federica; Laghi, Vio...la; Ma, Johnny; Galuppi, Andrea; Cilla, Savino; Buwenge, Milly; Macchia, Gabriella; Zamagni, Claudio; Tagliaferri, Luca; Perrone, Anna Myriam; De Iaco, Pierandrea; Strigari, Lidia; Morganti, Alessio Giuseppe; Arcelli, Alessandra | 2023-01-01 | JOURNAL OF PERSONALIZED MEDICINE | - | 1.01 Articolo in rivista | jpm-13-01229-v2 (1).pdf |
| Combination of Electrochemotherapy with Radiotherapy: A Comprehensive, Systematic, PRISMA-Compliant Review of Efficacy and Potential Radiosensitizing Effects in Tumor Control | Ferioli, Martina; Perrone, Anna M; Buwenge, Milly; Arcelli, Alessandra; Vadala', Maria; Fionda, B...runo; Malato, Maria C; De Iaco, Pierandrea; Zamagni, Claudio; Cammelli, Silvia; Tagliaferri, Luca; Morganti, Alessio G | 2023-01-01 | CURRENT ONCOLOGY | - | 1.01 Articolo in rivista | curroncol-30-00719.pdf |
| Factors predicting BRCA1/2 pathogenic variants in patients with ovarian cancer: a systematic review with meta-analysis | Innella, Giovanni; Godino, Lea; Erini, Giulia; De Leo, Antonio; Santini, Donatella; Perrone, Anna... Myriam; De Iaco, Pierandrea; Zamagni, Claudio; Turchetti, Daniela | 2023-01-01 | JOURNAL OF CLINICAL PATHOLOGY | - | 1.01 Articolo in rivista | - |
| Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice | de Biase, Dario; Maloberti, Thais; Corradini, Angelo Gianluca; Rosini, Francesca; Grillini, Marco...; Ruscelli, Martina; Coluccelli, Sara; Altimari, Annalisa; Gruppioni, Elisa; Sanza, Viviana; Turchetti, Daniela; Galuppi, Andrea; Ferioli, Martina; Giunchi, Susanna; Dondi, Giulia; Tesei, Marco; Ravegnini, Gloria; Abbati, Francesca; Rubino, Daniela; Zamagni, Claudio; De Iaco, Pierandrea; Santini, Donatella; Ceccarelli, Claudio; Perrone, Anna Myriam; Tallini, Giovanni; De Leo, Antonio | 2023-01-01 | FRONTIERS IN MEDICINE | - | 1.01 Articolo in rivista | fmed-10-1146499.pdf; Table 1.DOCX |
| Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going | Mazzitelli C.; Santini D.; Corradini A.G.; Zamagni C.; Trere' D.; Montanaro L.; Taffurelli M. | 2023-01-01 | DIAGNOSTICS | - | 1.01 Articolo in rivista | - |
| Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival | Coada, Camelia Alexandra; Dondi, Giulia; Ravegnini, Gloria; Di Costanzo, Stella; Tesei, Marco; Fi...uzzi, Enrico; Di Stanislao, Marco; Giunchi, Susanna; Zamagni, Claudio; Bovicelli, Alessandro; Hrelia, Patrizia; Angelini, Sabrina; De Iaco, Pierandrea; Perrone, Anna Myriam | 2023-01-01 | JOURNAL OF GYNECOLOGIC ONCOLOGY | - | 1.01 Articolo in rivista | jgo-34-e82.pdf; jgo3482.zip |
| Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma | Perrone, Anna Myriam; Coada, Camelia Alexandra; Ravegnini, Gloria; De Leo, Antonio; Damiano, Gius...eppe; De Crescenzo, Eugenia; Tesei, Marco; Di Costanzo, Stella; Genovesi, Lucia; Rubino, Daniela; Zamagni, Claudio; De Iaco, Pierandrea | 2023-01-01 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - | 1.01 Articolo in rivista | ijgc-2022-004249.pdf |
| Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma | Ruscelli, Martina; Maloberti, Thais; Corradini, Angelo Gianluca; Rosini, Francesca; Querzoli, Giu...lia; Grillini, Marco; Altimari, Annalisa; Gruppioni, Elisa; Sanza, Viviana; Costantino, Alessia; Ciudino, Riccardo; Errani, Matteo; Papapietro, Alessia; Coluccelli, Sara; Turchetti, Daniela; Ferioli, Martina; Giunchi, Susanna; Dondi, Giulia; Tesei, Marco; Ravegnini, Gloria; Abbati, Francesca; Rubino, Daniela; Zamagni, Claudio; D'Angelo, Emanuela; De Iaco, Pierandrea; Santini, Donatella; Ceccarelli, Claudio; Perrone, Anna Myriam; Tallini, Giovanni; de Biase, Dario; De Leo, Antonio | 2023-01-01 | JOURNAL OF PERSONALIZED MEDICINE | - | 1.01 Articolo in rivista | jpm-13-00723-v3 (1).pdf |
| Management of malignant cutaneous wounds in oncologic patients | Starace M, Carpanese MA, Pampaloni F, Dika E, Pileri A, Rubino D, Alessandrini A, Zamagni C, Bara...ldi C, Misciali C, Patrizi A, Bianchi T, Apalla Z, Piraccini BM | 2022-01-01 | SUPPORTIVE CARE IN CANCER | - | 1.01 Articolo in rivista | 520_2022_Article_7194.pdf |
| Relevance of ARID1A Mutations in Endometrial Carcinomas | De Leo A.; Ravegnini G.; Musiani F.; Maloberti T.; Visani M.; Sanza V.; Angelini S.; Perrone A.M....; De Iaco P.; Corradini A.G.; Rosini F.; Grillini M.; Santini D.; Ceccarelli C.; Zamagni C.; Tallini G.; de Biase D. | 2022-01-01 | DIAGNOSTICS | - | 1.01 Articolo in rivista | diagnostics-12-00592-v2.pdf; diagnostics-12-00592-s001.zip |
| Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification | De Leo A.; de Biase D.; Lenzi J.; Barbero G.; Turchetti D.; Grillini M.; Ravegnini G.; Angelini S....; Zamagni C.; Coluccelli S.; Dondi G.; De Iaco P.; Perrone A.M.; Tallini G.; Santini D.; Ceccarelli C. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | DeLeo2021cancers-13-00950.pdf |
| COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak | Perrone A.M.; Dondi G.; Giunchi S.; De Crescenzo E.; Boussedra S.; Tesei M.; D'Andrea R.; De Leo ...A.; Zamagni C.; Morganti A.G.; De Palma A.; De Iaco P. | 2021-01-01 | GYNECOLOGIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma | Giacomo Santandrea, Claudio Ceccarelli, Donatella Santini, Daniela Turchetti, Claudio Zamagni, An...na Myriam Perrone, Pierandrea De Iaco, Antonio De Leo | 2021-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| Radiotherapy in uterine sarcoma: a narrative review of international guidelines | Ferioli, Martina; Galuppi, Andrea; Perrone, Anna Myriam; De Iaco, Pierandrea; Zamagni, Claudio; B...uwenge, Milly; Morganti, Alessio Giuseppe; Cammelli, Silvia | 2021-01-01 | GYNECOLOGY AND PELVIC MEDICINE | - | 1.01 Articolo in rivista | - |
| A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results | Cortesi, Laura; Baldassarri, Bruna; Ferretti, Stefano; Razzaboni, Elisabetta; Bella, Mariangela; ...Bucchi, Lauro; Canuti, Debora; De Iaco, Pierandrea; De Santis, Giorgio; Falcini, Fabio; Galli, Vania; Godino, Lea; Leoni, Maurizio; Perrone, Anna Myriam; Pignatti, Marco; Saguatti, Gianni; Santini, Donatella; Sassoli de'Bianchi, Priscilla; Sebastiani, Federica; Taffurelli, Mario; Tazzioli, Giovanni; Turchetti, Daniela; Zamagni, Claudio; Naldoni, Carlo | 2020-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | Cortesi_et_al-2020-Cancer_Medicine.pdf |
| HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer | Wurfel F.M.; Wirtz R.M.; Winterhalter C.; Taffurelli M.; Santini D.; Mandrioli A.; Veltrup E.; Ru...bner M.; Fasching P.A.; Wurfel W.; Zamagni C. | 2020-01-01 | GEBURTSHILFE UND FRAUENHEILKUNDE | - | 1.01 Articolo in rivista | a-1128-6664(1).pdf |
| A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed | Ceccarelli C.; De Leo A.; Chieco P.; Zamagni C.; Zamagni A.; Rubino D.; Taffurelli M.; Santini D. | 2019-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | PlosONE Ceccarelli et al. journal.pone.0217937-1.pdf |
| High-grade serous carcinoma: a comprehensive genetic and clinico-pathologic study of a heterogeneous neoplasm. | G. Santandrea, A. De Leo, C. Ceccarelli, G. Barbero, S. Ferrari, D. Turchetti, D. Rubino, C. Zama...gni, G. Dondi, A.M. Perrone, P. De Iaco, D. Santini. | 2019-01-01 | PATHOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
| Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial | Dieci M.V.; Bisagni G.; Brandes A.A.; Frassoldati A.; Cavanna L.; Giotta F.; Aieta M.; Gebbia V.;... Musolino A.; Garrone O.; Donadio M.; Rimanti A.; Beano A.; Zamagni C.; Soto Parra H.; Piacentini F.; Danese S.; Ferro A.; Cagossi K.; Sarti S.; Gambaro A.R.; Romito S.; Bazan V.; Amaducci L.; Moretti G.; Foschini M.P.; Balduzzi S.; Vicini R.; D'Amico R.; Griguolo G.; Guarneri V.; Conte P.F. | 2019-01-01 | BMC MEDICINE | - | 1.01 Articolo in rivista | HER2 2019.pdf |